TG Therapeutics Inc (TGTX.OQ)
TGTX.OQ on NASDAQ Stock Exchange Capital Market
4.75USD
14 Dec 2018
4.75USD
14 Dec 2018
Change (% chg)
-- (--)
-- (--)
Prev Close
$4.75
$4.75
Open
--
--
Day's High
--
--
Day's Low
--
--
Volume
--
--
Avg. Vol
398,451
398,451
52-wk High
$17.30
$17.30
52-wk Low
$4.20
$4.20
About
TG Therapeutics, Inc. (TG) is a biopharmaceutical company focused on the acquisition, development and commercialization of treatments for B-cell malignancies and autoimmune diseases. As of December 31, 2016, the Company was developing two therapies targeting hematological malignancies. TG-1101 (ublituximab) is a glycoengineered... (more)
Overall
| Beta: | 1.34 |
| Market Cap(Mil.): | $846.68 |
| Shares Outstanding(Mil.): | 68.84 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| TGTX.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 69.71 | 34.39 |
| EPS (TTM): | -1.95 | -- | -- |
| ROI: | -129.83 | 9.01 | 14.96 |
| ROE: | -133.51 | 10.15 | 16.52 |
Estimates